Tri-lo-sprintec Kit
Product Images NDC 71205-287

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tri-lo-sprintec (NDC 71205-287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister (Image 1)

FDA Label Image

Structure Formulas (Image 2)

FDA Label Image

Chart (Image 3)

Chart (Image 3)
This is a list of various methods of birth control including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The last option stated is not to use any birth control method at all.*
FDA Label Image

How To Use Blister (Image 4)

FDA Label Image

71205-287-28 (Image 6)

71205-287-28 (Image 6)
This text describes a medication called Tri-Lo-Sprintec used for contraceptive purposes, which contains norgestimate and ethinyl estradiol USP, and is manufactured by Teva Pharmaceuticals USA, Inc. The medication comes in the form of 28 day tablets and should be stored in a dry place at 20°C-25°C. The packaging includes warnings to keep out of children's reach. The medication has been relabeled by Proficient R LP and is available in different lots. The text includes several lot numbers and serial numbers, as well as a GTIN code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.